BOK Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34
| Closed | -$1.23K | – | 1298 |
|
|
2025
Q1 | $1.23K | Sell |
34
-7,942
| -100% | -$288K | ﹤0.01% | 1160 |
|
|
2024
Q4 | $336K | Buy |
7,976
+382
| +5% | +$16.1K | 0.01% | 621 |
|
|
2024
Q3 | $407K | Sell |
7,594
-722
| -9% | -$38.7K | 0.01% | 604 |
|
|
2024
Q2 | $342K | Buy |
8,316
+1,580
| +23% | +$64.9K | 0.01% | 669 |
|
|
2024
Q1 | $316K | Buy |
+6,736
| New | +$316K | 0.01% | 629 |
|
|
2020
Q1 | – | Sell |
-13,188
| Closed | -$563K | – | 904 |
|
|
2019
Q4 | $563K | Buy |
+13,188
| New | +$563K | 0.01% | 675 |
|